Abstract:Abstract Cardiac muscle contraction is driven by the molecular motor myosin that uses the energy from ATP hydrolysis to generate a power stroke when interacting with actin filaments, while it is unclear how this mechanism is impaired by mutations in myosin that can lead to heart failure. We have applied a Förster resonance energy transfer (FRET) strategy to investigate structural changes in the lever arm domain of human β-cardiac myosin subfragment 1 (M2β-S1). We exchanged the human ventricular regulatory light chain labeled at a single cysteine (V105C) with Alexa 488 onto M2β-S1, which served as a donor for Cy3ATP bound to the active site. We monitored the FRET signal during the actin-activated product release steps using transient kinetic stopped-flow measurements. We proposed that the fast phase measured with our FRET probes represents the structural change associated with rotation of the lever arm during the power stroke in M2β-S1. Our results demonstrated human cardiac muscle myosin has a slower power stroke compared with fast skeletal muscle myosin and myosin V. Measurements at different temperatures comparing the rate constants of the power stroke and phosphate release revealed that the power stroke occurs before phosphate release, and the two steps are tightly coupled. We speculate that the slower power stroke rate constant in cardiac myosin may correlate with the slower force development and/or unique thin filament activation properties in cardiac muscle. Additionally, we demonstrated that HCM (R723G) and DCM (F764L) associated mutations both reduced actin-activation of the power stroke in M2β-S1. We also demonstrate that both mutations decrease ensemble force development in the loaded in vitro motility assay. Thus, examining the structural kinetics of the power stroke in M2β-S1 has revealed critical mutation-associated defects in the myosin ATPase pathway, suggesting these measurements will be extremely important for establishing structure-based mechanisms of contractile dysfunction. Significance Mutations in human beta-cardiac myosin are known to cause various forms of heart disease, while it is unclear how the mutations lead to contractile dysfunction and pathogenic remodeling of the heart. In this study, we investigated two mutations with opposing phenotypes and examined their impact on ATPase cycle kinetics, structural changes associated with the myosin power stroke, and ability to slide actin filaments in the presence of load. We found that both mutations impair the myosin power stroke and other key kinetic steps as well as the ability to produce ensemble force. Thus, our results provide a structural basis for how mutations disrupt molecular level contractile dysfunction.

The Impact of Myosin Heavy Chain Isoforms on Contractile Behavior of the Heart

Alteration of Myocardial Sarcoplasmic Reticulum Ca2+ Transport Protein Expression in Neonatal Hypothyroid Rats

The effect of iodine deficiency and iodine excess on the expression of rat myocardial myosin heavy-chain mRNAs

Comparison of elementary steps of the cross-bridge cycle in rat papillary muscle fibers expressing α- and β-myosin heavy chain with sinusoidal analysis

Cardiomyopathy Mutations Impact the Power Stroke of Human Cardiac Myosin

Cardiac myosin motor deficits are associated with left ventricular dysfunction in human ischemic heart failure

Dynamics of β-cardiac myosin between the super-relaxed and disordered-relaxed states

Changes of the Contraction and Calcium Transients in Myocytes of Left Ventricle in Patients with Cardiac Hypertrophy and Heart Failure

Hormonal control of myosin heavy chain genes during development of skeletal muscles

A STUDY ON MORPHOMETRY OF MYOCARDIAL CELLS IN HYPOTHYROID RATS

A study of tropomyosin’s role in cardiac function and disease using thin-filament reconstituted myocardium

The effects of conditional loss of myosin binding protein H-like on cardiac function.

Diversity and Similarity of Motor Function and Cross-Bridge Kinetics in Papillary Muscles of Transgenic Mice Carrying Myosin Regulatory Light Chain Mutations D166V and R58Q.

Structural and Functional Aspects of the Myosin Essential Light Chain in Cardiac Muscle Contraction

Myosin Rod Hypophosphorylation and CB Kinetics in Papillary Muscles from a TnC-A8V KI Mouse Model.

Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations

Regulation of human heart contractility by essential myosin light chain isoforms

Molecular basis of force-pCa relation in MYL2 cardiomyopathy mice: Role of the super-relaxed state of myosin

Functional and Molecular Characterisation of Heart Failure Progression in Mice and the Role of Myosin Regulatory Light Chains in the Recovery of Cardiac Muscle Function

Decreased contractility and altered responses to inotropic agents in myocytes from tachypacing-induced heart failure canines

Effect of hypothyroidism on contractile performance of isolated end-stage failing human myocardium